Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits

Published:2007-09-01 Issue:1 Volume:26 Page:7-12
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Bhaskar Vinay,Fox Melvin,Breinberg Danna,Wong Melanie H-L,Wales Pauline E.,Rhodes Susan,DuBridge Robert B.,Ramakrishnan Vanitha

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-007-9078-z.pdf

Reference20 articles.

1. Folkman J (2003) Fundamental concepts of the angiogenic process. Curr Mol Med 3:643–651

2. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673–687

3. Stromblad S, Cheresh DA (1996) Integrins, angiogenesis and vascular cell survival. Chem Biol 3:881–885

4. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285:1028–1032

5. Hynes RO, Lively JC, McCarty JH, Taverna D, Francis SE, Hodivala-Dilke K, Xiao Q (2002) The diverse roles of integrins and their ligands in angiogenesis. Cold Spring Harbor Symp Quant Biol 67:143–153

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a new bisindolinone arresting IGROV1 cells proliferation;European Journal of Medicinal Chemistry;2024-05

2. Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics;Frontiers in Oncology;2022-05-10

3. Integrin α5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma;Cancer Letters;2022-02

4. Antibody therapy in pancreatic cancer: mAb-ye we’re onto something?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-08

5. Integrins Within the Tumor Microenvironment: Biological Functions, Importance for Molecular Targeting, and Cancer Therapeutics Innovation;OMICS: A Journal of Integrative Biology;2021-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3